Amar Sawhney Email Address

President

OCULAR THERAPEUTIX, INC is a pharmaceutical company which specializes in ocular drug delivery, surgical sealants, sustained delivery, ophthalmic therapies, ophthalmology.

Amarpreet Sawhney is the President and CEO of Ocular Therapeutix, Inc. a company focused on unmet needs in ophthalmic surgical wound management and drug delivery. Previously, he was Founder and CEO of Confluent Surgical (acquired by Covidien), a biosurgery company, the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. he is also the CEO of Augmenix, Inc. He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped millions of patients worldwide. He has founded six companies, which account for over 1,600 jobs created and over $1.5 billion in revenue to date. Mr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of MassMedic, EcoSikh, Axtria, Ocular Therapeutix, Augmenix, and Incept LLC and is also a Founder of the last three companies. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.